跳至主要内容
临床试验/NCT00867971
NCT00867971Unknown不适用

Is Recombinant Growth Hormone Therapy Associated With Increased Intraoccular Pressure?

Assaf-Harofeh Medical Center1 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2009年2月最近更新:
适应症

试验速览

阶段
不适用
入组人数
100
试验地点
1
主要终点
Intraoccular pressure in children treated with RGH

研究概览

简要总结

Recombinant growth hormone is a common therapy in the pediatric population. A number of associated side effects have been described. Several years ago, a case report was published concerning a child that was treated with RGH and developed acute glaucoma. To date no study has evaluated the connection.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Cross Sectional

入排标准

年龄范围
6 Years 至 18 Years(Child, Adult)
性别
All
接受健康志愿者

入选标准

  • Age 6-18 years
  • treatment with recombinant growth hormone

排除标准

  • Underlying Chronic diseases
  • Family history of eye diseases
  • elevated occular pressure prior to starting treatment

结局指标

主要结局

Intraoccular pressure in children treated with RGH

时间窗: 2 years

次要结局

未报告次要终点

研究者

申办方类型
Other Gov

研究点 (1)

Loading locations...

相似试验